We offer our registered users tailored information, free online courses and exclusive content.
The official language of the live intervention is English.
For registration, accommodation and any logistic inquiry please contact:
Meridiano Congress International
Congress Manager: Titty Alvino
T +39 06 88 595 310 - F +39 06 88 595 234
The registration fee for the whole blended programme is EURO 150,00 and includes:
• Access to the online tutorials
• Scientific sessions
• Coffee breaks and luncheons
• Educational materials
• Certificate of attendance
Dinners are not included
Controlled ovarian stimulation (COS) now plays a major role in optimising IVF outcomes by facilitating control of different aspects of the process and increasing the number of oocytes available. COS aims to achieve maximal success with minimal side effects. Progress in and understanding of ovarian physiology, as well as new advances in ovarian stimulation strategies have made it possible for healthcare professionals to achieve the optimal outcomes for patients.
Success in assisted reproductive technology (ART) depends on carefully controlled conditions in every step of the laboratory routine. In addition, continuous advances in technology require constant revision of good laboratory practices and the introduction of new techniques. This educational activity will improve the participants’ knowledge of the latest technologies and laboratory practice guidelines.
The learning activity offers an interactive programme with specialised lectures tailored to fit the needs of physicians and embryologists working in ART, followed by lectures and case studies.
Learners will have the opportunity to discuss, directly with renowned scientists, pertinent topics that have been the subject of controversy and innovation. Discussions will concentrate on how to facilitate optimal laboratory conditions, culture environments, selection criteria and how to select the best therapy for infertile patients
By attending this live intervention, participants will be able to:
The CME course “Improving success in ART: how to define it and key strategies to get the bt outcomes” held on 8 December 2018 in Beijing, China, is designated for a maximum of 6 (six)es hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME ® credits are recognized by the American Medical Association (AMA) towards the Physician's Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.
Saturday, 8 December 2018
08.00 Registration
09.00 Introduction
R. Fischer, Germany
09.05 Welcome opening
Q. Yu, China
Session I
Chair: R. Fischer, Germany
Panelists: Yuan Li, China – H. Y. Choi, South Korea
09.10 L1 What is success in ART? Slide kit
P.C. Wong, Singapore
09.35 Question time
P.C. Wong, Singapore
09.45 L2 The importance of oocyte numbers for cumulative live-birth rates Slide kit
S. K. Sunkara, UK
10.10 Question time
S. K. Sunkara, UK
10.20 Panel discussion
10.55 Coffee break
Chair: R. Fischer, Germany
Panelist: D. Zhang, China
11.15 L3 How to define subgroups for COS? Slide kit
C. nVeetis, Australia
11.40 Question time
C. Venetis, Australia
11.50 L4 What kind and dose of gonadotropins to use in COS? Slide kit
C. Venetis, Australia
12.15 Question time
C. Venetis, Australia
12.25 Panel discussion
13.00 Lunch
Session II
Chair: R. Fischer, Germany
Panelists: Y. Xu, China – S. D. Kim, South Korea
14.00 L5 From poor response to low prognosis: The POSEIDON concept Slide kit
R. Fischer, Germany
14.25 Question time
R. Fischer, Germany
14.35 L6 The role of recent advancement in laboratory technology to improve ART outcome Slide kit
G. Coticchio, Italy
15.00 Question time
G. Coticchio, Italy
15.10 Panel discussion
15.40 Coffee break
Chair: R. Fischer, Germany
Panelists: Y. Ma, China – J. H. Lee, South Korea
16.00 L7 The role of pre-implantation testing for aneuploidy to improve selection. What are the limits? Slide kit
G. Coticchio, Italy
16.25 Question time
G. Coticchio, Italy
16.35 L8 Is the time ready for “freeze-all” strategy for all patients? What is the best frozen embryo transfer protocol? Slide kit
S. K. Sunkara, UK
17.00 Question time
S. K. Sunkara, UK
17.10 Panel discussion
17.40 Concluding remarks
R. Fischer, Germany
Q. Yu, China
17.45 End of the workshop
.
